Insider Transactions Reported by 20 Insiders of Accelerate Diagnostics, Inc

Location: Tucson, AZ

Quick Takeaways

Accelerate Diagnostics, Inc has 20 insiders with reported activity on this page.
No net insider buy/sell flow is currently reported for the last year.
Recent transaction rows are not currently available.

What Changed

No meaningful buy/sell imbalance is currently visible in the one-year window.
Activity will update as new Forms 3/4/5 are filed.

Why This Matters

This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.

Source Evidence

Filed on Form 4

Issuer insider activity is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Insider trading overview

Last 12 months

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 20 Apr 2025.

Buys

Shares: 0

Insiders: 0

Sells

Shares: 0

Insiders: 0

Net

Shares: 0

Insiders: 0

Window (months)	Buy $	Sell $	Net $
0-3	$0	$0	$0
3-6	$0	$0	$0
6-9	$0	$0	$0
9-12	$0	$0	$0

Accelerate Diagnostics, Inc executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Valuation	Report Date
Jack W. Schuler	Director, 10%+ Owner	$13,104,365	Mixed	03 Dec 2024
Matthew W. Strobeck	Director	$2,467,531	Mixed	23 Jan 2024
John Patience	Director	$1,419,801	Mixed	03 Dec 2024
Marran H. Ogilvie	Director	$1,098,403	Mixed	20 May 2024
Mark S. Black	Director	$1,098,403	Mixed	20 May 2024
Jennifer Regan	Director	$1,067,524	Mixed	29 May 2024
Wayne Burris	Director	$1,043,428	Mixed	31 May 2024
Steven Reichling	Chief Financial Officer	$625,004	Mixed	13 Mar 2023
Thomas D. Brown	Director	$509,942	Mixed	19 May 2023
Mark C. Miller	Director	$414,170	Mixed	07 Mar 2023
Charles M. Watts	Director	$305,627	Mixed	19 May 2023
Brink Frank Jm Ten	Director	$266,412	Mixed	03 Mar 2023
Ron Price	Head of Commercial Operations	$178,278	Mixed	21 Apr 2022
Jack Phillips	Chief Executive Officer, Director	$124,393	Filing P/S	04 Apr 2025
David Patience	Chief Financial Officer	$67,683	Mixed	01 Apr 2025
Larry Michael Mertz	Chief Technology Officer	$55,122	Filing P/S	04 Apr 2025
Hany Massarany	Director	$51,777	Mixed	28 Jun 2024
Louise Francesconi	Director	$46,204	Mixed	28 Jun 2024
Gilbert E. Nathan	Director		Mixed	10 Apr 2025
Paul Vincent Shalhoub	Director		Mixed	10 Apr 2025

Top shareholders of Accelerate Diagnostics, Inc (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Jack W. Schuler	3/4/5	Director, 10%+ Owner	— mixed-class rows	11,071,820 mixed-class rows	$13,104,365	—	03 Dec 2024	3/4/5
Matthew W. Strobeck	3/4/5	Director	— mixed-class rows	662,080 mixed-class rows	$2,467,531	—	23 Jan 2024	3/4/5
Indaba Capital Management, L.P.	13D/G	—	9.9%	2,751,762	$2,146,374	$0	04 Feb 2025	13D/G
John Patience	3/4/5	Director	— mixed-class rows	954,544 mixed-class rows	$1,419,801	—	03 Dec 2024	3/4/5
Mark S. Black	3/4/5	Director	— mixed-class rows	303,509 mixed-class rows	$1,098,403	—	20 May 2024	3/4/5
Marran H. Ogilvie	3/4/5	Director	— mixed-class rows	303,509 mixed-class rows	$1,098,403	—	20 May 2024	3/4/5
Jennifer Regan	3/4/5	Director	— mixed-class rows	268,420 mixed-class rows	$1,067,524	—	29 May 2024	3/4/5
Wayne Burris	3/4/5	Director	— mixed-class rows	241,037 mixed-class rows	$1,043,428	—	31 May 2024	3/4/5
ARMISTICE CAPITAL, LLC	13D/G	—	7.4%	1,879,227	$995,990	-$105,350	31 Mar 2025	13D/G
Steven Reichling	3/4/5	Chief Financial Officer	— class O/S missing	142,370	$625,004	—	13 Mar 2023	3/4/5
GRIFFIN ASSET MANAGEMENT, INC.	13D/G	Griffin Asset Management, LLC	4%	1,003,581	$531,898	$0	31 Dec 2024	13D/G
Thomas D. Brown	3/4/5	Director	— class O/S missing	116,160	$509,942	—	19 May 2023	3/4/5
Mark C. Miller	3/4/5	Director	— class O/S missing	94,344	$414,170	—	07 Mar 2023	3/4/5
Charles M. Watts	3/4/5	Director	— class O/S missing	69,619	$305,627	—	19 May 2023	3/4/5
Brink Frank Jm Ten	3/4/5	Director	— class O/S missing	60,686	$266,412	—	03 Mar 2023	3/4/5
Ron Price	3/4/5	Head of Commercial Operations	— class O/S missing	40,610	$178,278	—	21 Apr 2022	3/4/5
Jack Phillips	3/4/5	Chief Executive Officer, Director	— class O/S missing	191,374	$124,393	—	04 Apr 2025	3/4/5
David Patience	3/4/5	Chief Financial Officer	— mixed-class rows	95,328 mixed-class rows	$67,683	—	01 Apr 2025	3/4/5
Larry Michael Mertz	3/4/5	Chief Technology Officer	— class O/S missing	84,803	$55,122	—	04 Apr 2025	3/4/5
Hany Massarany	3/4/5	Director	— mixed-class rows	75,504 mixed-class rows	$51,777	—	28 Jun 2024	3/4/5
Louise Francesconi	3/4/5	Director	— mixed-class rows	65,838 mixed-class rows	$46,204	—	28 Jun 2024	3/4/5

Recent Insider Transactions by Companies or Individuals for Accelerate Diagnostics, Inc

Showing up to 300 most recent insider transactions from the last 12 months.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership
No insider transactions were found in the last 12 months for this issuer.

* An asterisk sign (*) next to the price indicates that the price is likely invalid.